From the Corewell Health Orthopedics, Grand Rapids, MI (Hamilton and Menge), the Michigan State University College of Human Medicine, Grand Rapids, MI ( Hamilton and Menge), and the Corewell Health - Michigan State University, Grand Rapids, MI (Peterson and Buuck).
J Am Acad Orthop Surg. 2024 Dec 1;32(23):e1214-e1217. doi: 10.5435/JAAOS-D-24-00660. Epub 2024 Aug 13.
The American Academy of Orthopaedic Surgeons has developed Appropriate Use Criteria (AUC) for the Return to Play to Pre-Injury Level Following Anterior Cruciate Ligament (ACL) Injury . Evidence-based information, in conjunction with the clinical expertise of physicians, was used to develop the criteria to determine the appropriateness of return to play to pre-injury level after an ACL injury. The AUC for the Return to Play to Pre-Injury Level Following ACL Injury were derived by identifying clinical indications typical of patients wishing to return to play after an ACL injury. These indications were most often clinically significant parameters, including symptoms and diagnostic findings. In addition, "patient-level variables" (eg, activity level or demographics) can be considered. A total of 576 patient scenarios and 3 procedure recommendations were developed by the writing panel, a group of clinicians who are specialists in this AUC topic. Next, a separate multidisciplinary rating panel (made up of specialists and nonspecialists) rated the appropriateness of treatment of each patient scenario using a 9-point scale to designate a treatment as "appropriate" (median rating, 7 to 9), "may be appropriate" (median rating, 4 to 6), or "rarely appropriate" (median rating, 1 to 3).
美国矫形外科医师学会已经制定了前交叉韧带(ACL)损伤后恢复到受伤前运动水平的适当使用标准(AUC)。该标准的制定结合了循证信息和医生的临床专业知识,旨在确定 ACL 损伤后恢复到受伤前运动水平的适当性。ACL 损伤后恢复到受伤前运动水平的 AUC 通过确定临床上常见的希望 ACL 损伤后重返运动的患者的临床指征来得出。这些指征通常是具有临床意义的参数,包括症状和诊断发现。此外,还可以考虑“患者个体变量”(例如,活动水平或人口统计学特征)。写作小组(一群在 AUC 主题方面具有专长的临床医生)共制定了 576 个患者情况和 3 项手术建议。接下来,一个由专家和非专家组成的独立多学科评估小组使用 9 分制对每个患者情况的治疗适宜性进行了评估,以指定治疗为“适当”(中位数评分 7 到 9)、“可能适当”(中位数评分 4 到 6)或“很少适当”(中位数评分 1 到 3)。